GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » GF Value

Tellgen (SZSE:300642) GF Value : ¥16.53 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Tellgen GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-24), Tellgen's share price is ¥11.22. Tellgen's GF Value is ¥16.53. Therefore, Tellgen's Price-to-GF-Value for today is 0.68.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Tellgen is Significantly Undervalued.

Tellgen  (SZSE:300642) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Tellgen's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=11.22/16.53
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tellgen GF Value Related Terms

Thank you for viewing the detailed overview of Tellgen's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Tellgen (SZSE:300642) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » GF Value
Comparable Companies
SZSE:300246 SHSE:688613 SZSE:301033 SZSE:301290 SZSE:300813 SHSE:688273 SZSE:301235 SZSE:301515 SHSE:688314 SHSE:688656 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 115, Lane 572, Bibo Road, Building 1, Zhangjiang Hi-Tech Park, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Website
http://www.tellgen.com
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Executives
Zhou Ai Guo Directors, executives
Chen Si Han Securities Affairs Representative

Tellgen (SZSE:300642) Headlines

No Headlines